Researchers advance scalable stem-cell bioprocessing with AI-enabled manufacturing for regenerative medicine therapies.

After a median follow-up of 10 years, more than one-third of patients with large B-cell lymphoma and nearly half of patients ...

UCI Health, the clinical enterprise of the University of California, Irvine, has opened the world's first in-human embryonic stem cell-derived clinical trial for Huntington's disease.

Though surprised to learn he was a match for a woman battling a rare blood disease, the college student from Lake Mary will ...

The 2026 Warren Alpert Foundation Prize has been awarded to five scientists for their work leading to curative genetic ...

Around a third of people are able to almost fully rebuild their brains after a stroke and uncovering why is pointing the way ...

Thanks to community fundraising, Driscoll Children's Hospital is expanding craniofacial care for South Texas kids.

The FDA has approved sacituzumab govitecan-hziy as first-line therapy for adults with unresectable locally advanced or ...

Vascular disease represents a major contributor to global cardiovascular mortality, characterized by structural and ...

Below are summaries of recent Fred Hutch Cancer Center research findings, patient stories and other news. If you’re interested in reporting on any of this month’s stories, contact media@fredhutch.org ...

A gene therapy that instructs cells to produce more of an anti-ageing protein called klotho is about to be offered by a US ...

Sangamo Therapeutics ran out of cash. Eli Lilly and Astellas want the science it spent decades building.